Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synflorix (PCV10) Immunogenicity in Kenyan Children (PRISM)
NCT01028326Phase 4Unknown
- Sponsor
- KEMRI-Wellcome Trust Research Programme
- Start
- Jan 2010
- Primary completion
- Sep 2010
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of 10-valent pneumococcal conjugate vaccine in Pneumococcal pneumonia (PP), sponsored by KEMRI-Wellcome Trust Research Programme. Status: unknown.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
Pneumococcal pneumonia (PP)
Beyond the preview
Go deeper on NCT01028326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01028326.